BlackRock Fund Advisors - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$27,898,000
-29.4%
6,837,786
+9.8%
0.01%
-37.5%
Q3 2016$39,540,000
+30.2%
6,226,723
+10.5%
0.01%
+14.3%
Q2 2016$30,376,000
-31.3%
5,635,702
+6.7%
0.01%
-30.0%
Q1 2016$44,222,000
+6.4%
5,283,448
+0.4%
0.01%0.0%
Q4 2015$41,567,000
-6.5%
5,261,702
+0.8%
0.01%
-16.7%
Q3 2015$44,437,000
-31.4%
5,221,783
-0.3%
0.01%
-25.0%
Q2 2015$64,742,000
+9.4%
5,235,904
+5.1%
0.02%
+14.3%
Q1 2015$59,175,000
+10.3%
4,981,073
+5.0%
0.01%
+7.7%
Q4 2014$53,626,000
+40.7%
4,745,667
+9.3%
0.01%
+18.2%
Q3 2014$38,117,000
+24.4%
4,341,343
+3.3%
0.01%
+22.2%
Q2 2014$30,645,000
+66.2%
4,203,723
+14.9%
0.01%
+80.0%
Q1 2014$18,441,000
-2.4%
3,658,982
+3.2%
0.01%
-16.7%
Q4 2013$18,895,000
+38.2%
3,544,276
-1.8%
0.01%
+20.0%
Q3 2013$13,674,000
-31.1%
3,607,884
+22.5%
0.01%
-28.6%
Q2 2013$19,857,0002,946,1660.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders